Mixed‐Genotype HCV Direct Acting Antiviral Outcomes: A CANUHC Analysis
Journal of Viral Hepatitis · 2024
DOI: 10.1111/jvh.13995 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Viral Hepatitis, 2024. Verfasst von Haris Imsirovic und 13 weiteren Autor:innen. Beteiligte Einrichtung: Ottawa Hospital Research Institute, Ottawa, Canada. Hauptthemen laut MEDLINE: Antiviral Agents, Hepacivirus, Genotype, Sustained Virologic Response. Die Arbeit nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
The prevalence of mixed hepatitis C virus (HCV) genotype infection in a representative Canadian HCV cohort is reported and virological response with direct acting antiviral (DAA) treatment was evaluated. 3272 HCV‐positive participants were enrolled, of which 2945 (90.0%) initiated DAA therapy. 0.8% were identified with mixed genotype infection. Overall sustained virological response (SVR) was 99.1% and did not differ based on mixed genotype status. Any historical disadvantage to achieving cure with HCV treatment in mixed genotype infection has been overcome by current DAA regimens.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Ottawa Hospital Research Institute, Ottawa, Canada.
- University of Calgary, Calgary, Canada.
- Vancouver Infectious Diseases Centre, Vancouver, British Columbia, Canada.
- University of Victoria, Victoria, Canada.
- William Osler Health System, Division of Infectious Diseases, Brampton, Canada.
- McMaster University, Division of Infectious Diseases, Hamilton, Canada.
Zitieren
APA
Imsirovic, H., Macphail, G., Conway, B., Fraser, C., Borgia, S., Smyth, D., Wong, A., Vachon, M. L., Webster, D., Liu, H., Feld, J., Lee, S., Cooper, C., & Canadian Network Undertaking against Hepatitis C (CANUHC) Cohort Investigator Team (2024). Mixed‐Genotype HCV Direct Acting Antiviral Outcomes: A CANUHC Analysis. Journal of Viral Hepatitis. https://doi.org/10.1111/jvh.13995
Vancouver
Imsirovic H, Macphail G, Conway B, Fraser C, Borgia S, Smyth D, et al. Mixed‐Genotype HCV Direct Acting Antiviral Outcomes: A CANUHC Analysis. Journal of Viral Hepatitis. 2024. doi:10.1111/jvh.13995
BibTeX
@article{Imsirovic2024,
author = {Imsirovic, Haris and Macphail, Gisela and Conway, Brian and Fraser, Chris and Borgia, Sergio and Smyth, Daniel and Wong, Alexander and Vachon, Marie-Louise and Webster, Duncan and Liu, Hongqun and Feld, Jordan and Lee, Sam and Cooper, Curtis and Canadian Network Undertaking against Hepatitis C (CANUHC) Cohort Investigator Team, Canadian Network Undertaking against Hepatitis C (CANUHC) Cohort Investigator Team},
title = {Mixed‐Genotype HCV Direct Acting Antiviral Outcomes: A CANUHC Analysis},
journal = {Journal of Viral Hepatitis},
year = {2024},
doi = {10.1111/jvh.13995}
}
EUVIMED